Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet's disease: multicentre retrospective study

Rheumatology
Belén Atienza-MateoRicardo Blanco

Abstract

To assess the efficacy of tocilizumab (TCZ) in refractory uveitis of Behçet's disease (BD). Multicentre study of patients with BD-associated uveitis. Patients were refractory to conventional and biologic immunosuppressive drugs. The main outcome measures were intraocular inflammation, macular thickness, visual acuity and corticosteroid-sparing effects. We studied 11 patients (7 men) (20 affected eyes); median age 35 years. Uveitis was bilateral in nine patients. The patterns of ocular involvement were panuveitis (n = 8, with retinal vasculitis in 4), anterior uveitis (n = 2) and posterior uveitis (n = 1). Cystoid macular oedema was present in seven patients. The clinical course was recurrent (n = 7) or chronic (n = 4). Before TCZ, patients had received systemic corticosteroids, conventional immunosuppressants and the following biologic agents: adalimumab (n = 8), infliximab (n = 4), canakimumab (n = 1), golimumab (n = 3), etanercept (n = 1). TCZ was used as monotherapy or combined with conventional immunosuppressants at 8 mg/kg/i.v./4 weeks (n = 10) or 162 mg/s.c./week (n = 1). At TCZ onset the following extraocular manifestations were present: oral and/or genital ulcers (n = 7), arthritis (n = 4), folliculitis/pseudofolliculit...Continue Reading

Associated Clinical Trials

References

Dec 12, 2002·European Journal of Ophthalmology·P C OzdalE Firat
Sep 15, 2004·American Journal of Ophthalmology·Ilknur Tugal-TutkunMeri Urgancioglu
Oct 1, 2005·American Journal of Ophthalmology·Douglas A JabsUNKNOWN Standardization of Uveitis Nomenclature (SUN) Working Group
Jul 11, 2007·Archives of Ophthalmology·Lucia SobrinC Stephen Foster
Nov 21, 2007·The British Journal of Ophthalmology·Nobuyoshi KitaichiHormoz Chams
Aug 20, 2008·Annals of Internal Medicine·Costantino BotsiosCharles A Dinarello
Dec 21, 2010·Seminars in Arthritis and Rheumatism·Aikaterini AridaPetros P Sfikakis
Aug 30, 2011·American Journal of Ophthalmology·Simon R J TaylorSue Lightman
Nov 15, 2011·Clinical Neurology and Neurosurgery·Lee S ShapiroAfshin Borhani Haghighi
Apr 25, 2012·Ophthalmology·Manuel Díaz-LlopisJ Fernando Arevalo
Oct 4, 2012·Ocular Immunology and Inflammation·Moncef KhairallahJohn H Kempen
Feb 28, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·UNKNOWN International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD)
Apr 6, 2013·Rheumatology·Andreas P Diamantopoulos, Gulen Hatemi
Dec 7, 2013·Clinical Rheumatology·Luca CantariniRolando Cimaz
Mar 7, 2014·Seminars in Immunology·Toshio TanakaTadamitsu Kishimoto
Mar 20, 2014·Dermatology : International Journal for Clinical and Investigative Dermatology·Antonio VitaleLuca Cantarini
Apr 16, 2014·Clinical Rheumatology·Luca CantariniFlorenzo Iannone
May 16, 2014·Clinical Reviews in Allergy & Immunology·Yilmaz OzyazganYusuf Yazici
Sep 28, 2014·Seminars in Arthritis and Rheumatism·Olga AddimandaCarlo Salvarani
Feb 24, 2015·Seminars in Arthritis and Rheumatism·Javier LoriceraMiguel Á González-Gay
Jun 21, 2015·Seminars in Arthritis and Rheumatism·Leyre Riancho-ZarrabeitiaMiguel A González-Gay
Sep 24, 2015·Clinical Ophthalmology·Phoebe Lin
Nov 12, 2015·Current Opinion in Rheumatology·Yesim Ozguler, Gulen Hatemi
Jan 9, 2016·Seminars in Arthritis and Rheumatism·Alban DerouxLaurence Bouillet
Mar 25, 2016·Acta Ophthalmologica·Sukhum Silpa-ArchaCharles Stephen Foster
Apr 12, 2016·Seminars in Arthritis and Rheumatism·Vanesa Calvo-RíoMiguel A González-Gay
Sep 8, 2016·The New England Journal of Medicine·Glenn J JaffeEric B Suhler
Nov 26, 2016·Best Practice & Research. Clinical Rheumatology·Sergio Schwartzman

❮ Previous
Next ❯

Citations

Feb 23, 2019·Modern Rheumatology·Mitsuhiro AkiyamaTsutomu Takeuchi
Dec 26, 2018·Internal Medicine Journal·Amruta Trivedi, Constance Katelaris
Apr 30, 2020·Rheumatology·Omer Karadag, Ertugrul Cagri Bolek
May 15, 2020·Expert Opinion on Biological Therapy·Miguel A González-GayJosé Hernández-Rodríguez
Jul 24, 2020·Expert Review of Clinical Immunology·Carla GaggianoClaudia Fabiani
Jun 9, 2020·Frontiers in Pharmacology·Rodrigo A ValenzuelaCristhian A Urzua
Jan 27, 2019·Internal and Emergency Medicine·Sinem Nihal Esatoglu, Gulen Hatemi
Sep 5, 2020·Expert Opinion on Drug Safety·Giuseppe LopalcoFlorenzo Iannone
Apr 13, 2019·Rheumatology International·Dimitri PoddigheMaikesh Assylbekova
Jan 11, 2020·Frontiers in Immunology·Alessandra BettiolGiacomo Emmi
Nov 5, 2020·Expert Opinion on Emerging Drugs·Ilknur Tugal-Tutkun, Pinar Çakar Özdal
Jan 23, 2021·Asia-Pacific Journal of Ophthalmology·Lisia Barros FerreiraJustine R Smith
Nov 12, 2020·Journal of Clinical Medicine·Mathilde LeclercqDavid Saadoun
Feb 20, 2021·Seminars in Arthritis and Rheumatism·Mónica Calderón-GoerckeUNKNOWN Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group
Feb 27, 2021·International Ophthalmology·Uwe PleyerChristoph Deuter
Feb 20, 2021·Journal of Experimental Pharmacology·Burçin Cansu Bozca, Erkan Alpsoy
Feb 23, 2021·American Journal of Ophthalmology Case Reports·Ahmad Al-MoujahedQuan Dong Nguyen
Apr 6, 2021·Journal of Immunology Research·Kailei Guo, Xiaomin Zhang
Apr 30, 2021·Frontiers in Immunology·Masaki TakeuchiShigeaki Ohno
Oct 3, 2020·The Journal of Rheumatology·José Luis Martín-VarillasUNKNOWN Ricardo Blanco on behalf of the Spanish Collaborative Group of Refractory Behçet’s Disease
May 21, 2021·Current Rheumatology Reports·Fatma Alibaz-Oner, Haner Direskeneli
Jun 3, 2021·Journal of Clinical Medicine·Julie GueudryBahram Bodaghi
Jul 16, 2021·Expert Review of Clinical Immunology·Sara TouhamiBahram Bodaghi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.